Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution

被引:0
作者
Masashi Kubota
Hidetoshi Kokubun
Ritsuki Yamaguchi
Shiori Murata
Noriyuki Makita
Issei Suzuki
Ryosuke Suzuki
Yohei Abe
Yoichiro Tohi
Naofumi Tsutsumi
Yoshio Sugino
Koji Inoue
Mutsushi Kawakita
机构
[1] Kobe City Medical Center General Hospital,Department of Urology
来源
International Journal of Clinical Oncology | 2020年 / 25卷
关键词
Bladder cancer; Cystectomy; Peritoneal carcinomatosis; Port site; Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1385 / 1392
页数:7
相关论文
共 43 条
[1]  
Stein JP(2001)Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients J Clin Oncol 19 666-675
[2]  
Lieskovsky G(2012)Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes Eur Urol 61 350-355
[3]  
Cote R(2008)Laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis Eur Urol 54 54-62
[4]  
Desai MM(2015)Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer Eur Urol 68 399-405
[5]  
Berger AK(2017)Early oncologic failure after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium J Urol 197 1427-1436
[6]  
Brandina RR(2017)Evidence of atypical recurrences after robot-assisted radical cystectomy: a comprehensive review of the literature Bladder Cancer 3 231-236
[7]  
Haber GP(2018)Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: oncologic outcomes Eur Urol 74 465-471
[8]  
Crouzet S(2016)Critical analysis of early recurrence after laparoscopic radical cystectomy in a large cohort by the ESUT J Urol 195 1710-1717
[9]  
Gill IS(2020)Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: a Japanese multicenter cohort Int J Urol 27 250-256
[10]  
Nguyen DP(2018)Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial Lancet 391 2525-2536